Substancje pochodzenia farmaceutycznego jako wyłaniające się zagrożenie dla środowiska wodnego

• Autorzy: Szczotka A. , Gąszczak A. , Bartelmus G.

Warianty tytułu

EN

Pharmaceuticals in the aquatic environment

• Języki publikacji: PL

Abstrakty

PL

W pracy przedstawione zostały zagadnienia związane z obecnością w środowisku wodnym związków pochodzenia farmaceutycznego. Omówiono najważniejsze drogi przedostawania się leków do wód, problemy związane z oceną ryzyka ekotoksykologicznego oraz losy leków w oczyszczalniach ścieków.

EN

The key issues concerning the presence of pharmaceuticals in the aquatic environment are presented. The most important pathways of drugs entering aquatic ecosystems, problems associated with ecotoxicological risk assessment and the fate of pharmaceuticals in conventional wastewater treatment plants are discussed.

Słowa kluczowe

PL

farmaceutyki; wody naturalne; oczyszczalnie ścieków

• Wydawca: Instytut Inżynierii Chemicznej Polskiej Akademii Nauk
• Czasopismo: Prace Naukowe Instytutu Inżynierii Chemicznej Polskiej Akademii Nauk
• Rocznik: 2014
• Tom: nr 18
• Strony: 5--16
• Opis fizyczny: Bibliogr. 31 poz., tab.

Twórcy

autor

Szczotka A.

• Instytut Inżynierii Chemicznej PAN Gliwice, ul. Bałtycka 5, 44-100 Gliwice

autor

Gąszczak A.

• Instytut Inżynierii Chemicznej PAN Gliwice, ul. Bałtycka 5, 44-100 Gliwice

autor

Bartelmus G.

• Instytut Inżynierii Chemicznej PAN Gliwice, ul. Bałtycka 5, 44-100 Gliwice

Bibliografia

• [1] RIVERA-UTRILLA J., SÁNCHEZ-POLO M., FERRO-GARCÍA M.Á., PRADOS-JOYA G., OCAMPO-PÉREZ R., Pharmaceuticals as emerging contaminants and their removal from water. A review., Chemosphere 2013, 93, 1268.
• [2] JOSS A., ŻABCZYNSKI S., GÖBEL A., HOFFMANN B., LÖFFLER D., MCARDELL C.S., TERNES T.A., THOMSEN A., SIEGRIST H, Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Res. 2006, 40, 1686.
• [3] SOSNOWSKA K., GROCHOWIAK-STYSZKO K., GOŁAS J., Leki w środowisku – źródła, przemiany, zagrożenia. Krakowska Konferencja Młodych Uczonych, 2009.
• [4] FARRÉ M., PÉREZ S., KANTIANI L., BARCELÓ D., Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. Trends Anal. Chem. 2008, 27, 991.
• [5] HALLING-SORENSEN B., NIELSEN N.S., LANZKY S.F., INGERSLEV F., Occurrence, fate, and effects of pharmaceutical substances in the environment – a rewiev. Chemosphere, 1998, 36, 357.
• [6] DAUGHTON C.G., TERNES T.A., Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Persp. 1999,107, 907.
• [7] HEBERER T., Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131, 5.
• [8] FLAHERTY C.M., DODSON S.I. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere, 2005, 61, 200.
• [9] BACKHAUS T., SUMPTER J., BLANCK H., On the ecotoxicology of pharmaceutical mixtures in Pharmaceuticals in the environment, 2008, 257.
• [10] RICHARDS S.M., WILSON C.J., JOHNSON D.J., CASTLE D.M., LAM M., MABURY S.A., SIBLEY P.K., SOLOMON K.R., Effects of pharmaceutical mixtures in aquatic microcosms. Environ. Toxicol. Chem. 2004, 23, 1035.
• [11] TERNES T.A., Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse, raport końcowy projektu Poseidon, 2004.
• [12] VALCARCEL Y., GONZALEZ ALONSO S., RODRIGUEZ-GIL J.L., Analysis of the presence of cardiovascular, analgesic, anti-inflammatory, antipyretic pharmaceuticals in river and drinking water of the Madrid Region of Spain, Chemosphere 2011, 82, 1062.
• [13] TOGOLA A., BUDZINSKI H., Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A, 2008, 1177, 150.
• [14] KOLPIN D.W., FURLONG E.T., MEYER M.T., THURMAN E.M., ZAUGG S.D., BARBER L.B., BUXTON H.T., Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202. doi: 10.1021/es011055j.
• [15] KASPRZYK-HORDERN B., DINSDALE R.M., GUWY A.J., Multi-residue method for the determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J. Chromatogr. A, 2007 1161, 132.
• [16] BUSER H.R., MULLER M.D., THEOBALD N., Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci. Technol. 1998, 32, 188.
• [17] TERNES T.A., STUMPF M., MUELLER J., HABERER K., WILKEN R.D., SERVOS M., Behavior and occurrence of estrogens in municipal sewage treatment plants – I. Investigations in Germany, Canada and Brazil. Sci. Total Environ. 1999, 225, 81.
• [18] RADJENOVIC J., PETROVIC M., BARCELO D., Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal. Bioanal. Chem. 2007, 387, 1365. doi:10.1007/s00216-006-0883-6.
• [19] QUINTANA J.B., WEISS S., REEMTSMA T., Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005, 39, 2654.
• [20] ROBERTS P.H., THOMAS K.V., The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356, 143.
• [21] STUMPF M., TERNES T.A., WILKEN R.D., RODRIGUES S.V., BAUMANN W., Polar drug residues in sewage and natural waters in the state of Rio de Janeiro. Brazil. Sci. Total Environ. 1999, 225, 135. doi:10.1016/S0048-9697(98)00339-8.
• [22] JONES O.A.H., VOULVOULIS N., LESTER J.N., The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ. Pollut 2007, 145, 738. doi:10.1016/j.envpol.2005.08.077.
• [23] GOMEZ M.J., MARTINEZ BUENO M.J., LACORTE S., FERNANDEZ-ALBA A.R., AGUERA A., Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007, 66, 993. doi:10.1016/j.chemosphere.2006.07.051.
• [24] TERNES T.A., Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32, 3245.
• [25] CASTIGLIONI S., BAGNATI R., FANELLI R., POMATI F., CALAMARI D., ZUCCATO E., Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40, 357. doi:10.1021/es050991m.
• [26] CLARA M., STRENN B., GANS O., MARTINEZ E., KREUZINGER N., KROISS H., Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39, 4797. doi:10.1016/j.watres.2005.09.015.
• [27] KARTHIKEYAN K.G., MEYER M.T., Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. Sci. Total Environ. 2006, 361, 196.
• [28] BARONTI C., CURINI R., D'ASCENZO G., DI CORCIA A., GENTILI A., SAMPERI R., Monitoring natural and synthetic estrogens at activated sludges sewage treatment plants and in a receiving river water, Environ. Sci. Technol. 2000, 34, 5059.
• [29] JOSS A., ANDERSEN H., TERNES T., RICHLE P.R., SIEGRIST H., Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ. Sci. Technol. 2004, 38, 3047. doi:10.1021/es0351488.
• [30] SUÁREZ S., CARBALLA M., OMIL F., LEMA J.M., How are pharmaceuticals and personal care products (PPCPs) removed from urban wastewaters?. Rev. Environ. Sci. Biotechnol. 2008, 7, 125-138.
• [31] CLARA M., KREUZINGER N., STRENN B., GANS O., KROISS H., The solids retention time – a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants., Water Res. 2005, 39, 97.